U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. COBAS TaqScreen MPX Test
  1. Vaccines, Blood & Biologics

COBAS TaqScreen MPX Test

STN: BL125255
Proper Name: Human Immunodeficiency Virus Type 1 (HIV-1) Group M RNA, HIV-1 Group O RNA, Human Immunodeficiency Virus Type 2 (HIV-2) RNA, Hepatitis C Virus (HCV) RNA and Hepatitis B Virus (HBV) DNA Assay
Tradename: COBAS TaqScreen MPX Test
Manufacturer: Roche Molecular Systems, Inc, License No. 1636

In the February 26, 2009 Corrected Approval Letter. Correction is made to (1) reflect that specimens from "other living donors" are not included in those specimens that can be tested in pools of up to six (change in original second paragraph, line 2), (2) clarify the claim for detection of HIV-1 Group O RNA and HIV-2 RNA (change in original second paragraph line 7), and (3) clarify that the test may be used to screen donations of Source Plasma under certain conditions (change in original third paragraph, line 1).

Package Insert

Supporting Documents

Back to Top